Update on Gestational Diabetes

Obstetrics and Gynecology Clinics of North America

Volumn 37, Issue 2, 2010, Pages 255-267

  Pridjian, Gabriella ^a   Benjamin, Tara D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gestational diabetes; Glyburide; Insulin; Pregnancy complications

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLIBENCLAMIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; ISOPHANE INSULIN; LONG ACTING INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIG INSULIN; ANTIDIABETIC AGENT;

ARTICLE; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CESAREAN SECTION; DIET THERAPY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; EVENING DOSAGE; EXERCISE; FETUS RISK; FIRST TRIMESTER PREGNANCY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAPARTUM CARE; LOW CARBOHYDRATE DIET; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; SHOULDER DYSTOCIA; STEADY STATE; THIRD TRIMESTER PREGNANCY; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; WEIGHT REDUCTION; DIET; FEMALE; FETUS DISEASE; METABOLISM; PREGNANCY; REVIEW;

BLOOD GLUCOSE; DIABETES, GESTATIONAL; DIET; EXERCISE; FEMALE; FETAL DISEASES; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; RISK FACTORS;

EID: 78650788839     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2010.02.017     Document Type: Article

References (75)

1. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30:S251-60.
2. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity amongU.S. children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-50.
3. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998; 21:B19-26.
4. Phelps RL, Metzger BE, Freinkel N. Carbohydrate metabolism in pregnancy XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am J Obstet Gynecol 1981;140:730-6.
5. Butte N. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000;71:1256S-61S.
6. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: betacell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 1997;29(6):301-7.
7. Van Assche F, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 1978;85:818-20.
8. Assel B, Rossi K, Kalhan S. Glucose metabolism during fasting through human pregnancy: comparison of tracer method with respiratory calorimetry. Am J Phys 1993;265:E351-6.
9. Catalano P, Tyzbir E, Wolfe R, et al. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol 1992;167:913.
10. Kalhan SC, D'Angelo LJ, Savin SM, et al. Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. J Clin Invest 1979;63:388-94.
11. Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 1991;165:1667-72.
12. Fisher P, Sutherland H, Bewsher P. The insulin response to glucose infusion in normal human pregnancy. Diabetologia 1980;19:15-20.
13. Sivan E, Chen X, Homko CJ, et al. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care 1997;20:1470-5.
14. Buchanan TA, Metzger BE, Frienkel N, et al. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990;162:1008-14.
15. Damm P, Handber A, Kuhl C, et al. Insulin receptor binding and tryrosine kinase activity in skeletal muscle from normal pregnant women and women with gestational diabetes. Obstet Gynecol 1993;82:251-9.
16. Shao J, Catalano PM, Yamashita H, et al. Impaired insulin receptor tyrosine kinase activity and over expression of PC-1 in skeletal muscle from obese women with gestational diabetes. Diabetes 2000;49:603-10.
17. Friedman JE, Ishizuka T, Huston L, et al. Impaired glucose transport and insulin receptor tyrosine kinase phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999;48:1807-14.
18. Okuno S, Akazawa S, Yasuhi I, et al. Decreased expression of GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm Metab Res 1995; 27:231-4.
19. Kirwan JP, Hauguel-de Mouson S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207-13.
20. Highman TJ, Friedman JE, Huston LP, et al. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1999;178:1010-5.
21. Henson MC, Swan KF, O'Neal JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol 1998;92:1020-8.
22. Devlieger R, Casteels K, van Assche FA. Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring. Acta Obstet Gynecol 2008;87: 1266-70.
23. Catalano PM, Huston L, Amini SB, et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol 1999;180:903-16.
24. Jarrett RJ. Gestational diabetes: a non-entity? BMJ 1993;306:37-8.
25. Langer O, Yogev Y, Most O, et al. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192:989-97.
26. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-86.
27. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2.
28. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009;58:453-9.
29. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-48.
30. Gabbe SG, Gregory RP, Power ML, et al. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004;103:1229-34.
31. ACOG Practice Bulletin No. 30. American College of Obstetricians and Gynecologists. Gestational diabetes. Obstet Gynecol 2001;98:525-38.
32. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004;27:S88-90.
33. U.S.Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:759-65.
34. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and categories of glucose intolerance. Diabetes 1979;28:1039-57.
35. Carpenter MR, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.
36. Reece EA, Laguizamon G, Wiznitzer A. Gestational diabetes: the need for common ground. Lancet 2009;373:1789-97.
37. Torloni MR, Betran AP, Horta BL, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10:194-203.
38. Chu S, Kim SY, Lau J. Re: prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10: 489-90.
39. McGuire V, Rauh MJ, Mueller BA, et al. The risk of diabetes in a subsequent pregnancy associated with prior history of gestational diabetes or a macrosomic infant. Paediatr Perinat Epidemiol 1996;10:64-72.
40. Cypryk K, Szymczak W, Czupryniak L, et al. Gestational diabetes - an analysis of risk factors. Endokrynol Pol 2008;59:393-7.
41. Xiong X, Saunders LD, Wang FL, et al. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynecol Obstet 2001; 75:221-8.
42. Rauh-Hain JA, Rana S, Tamez H, et al. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med 2009;22:293-9.
43. Dornhorst A, Paterson CM, Nicholls JSD, et al. High prevalence of gestational diabetes in women for ethnic minority groups. Diabetic Medicine 1992;9:820-5.
44. Dooley S, Metzger B, Cho N, et al. Gestational diabetes mellitus: influence of race on disease prevalence and perinatal outcome in the US population. Diabetes 1991;20(Supple 2):25-9.
45. Toulis KA, Goulis DG, Kolibianakis EM, et al. Risk of gestational diabetes mellitus in women with polycystic ovarian syndrome: a systematic review and a metaanalysis. Fertil Steril 2009;92(2):667-77.
46. Kim C, Liu T, Valdez R, et al. Does frank diabetes in first degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes? Am J Obstet Gynecol 2009;201:576, e1-6.
47. Xiong X, Ellkind-Hirsch KE, Vastardis S, et al. Periodontal disease is associated with gestational diabetes mellitus, a case-control study. J Periodontol 2009;80: 1742-9.
48. Dasanayake AP, Chhun N, Tanner AC, et al. Periodontal pathogens and gestational diabetes mellitus. J Dent Res 2008;87:328-33.
49. Seghieri G, Anichini R, de Bellis A, et al. Relationship between gestational diabetes mellitus and low maternal birth weight. Diabetes Care 2002;25:1761-5.
50. Chen L, Hu FB, Yeung E, et al. Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus. Diabetes Care 2009;32(12):2236-41.
51. Langer O, Levy J, Brustman L, et al. Glycemic control in gestational diabetes - how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;61:646-53.
52. Salvesen DR, Brudenell JM, Proudler AJ, et al. Fetal pancreatic beta-cell function in pregnancies complicated by maternal diabetes mellitus: relationship to fetal macrosomia. Am J Obstet Gynecol 1993;168:1363-9.
53. Sacks DA, Liu AI, Wolde-Tsadik G, et al. What proportion of birth weight is attributable to maternal glucose among infants of diabetic mothers? Am J Obstet Gynecol 2006;194:501-7.
54. Catalano PM, Presley MS, Minium J, et al. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009;32:1076-80.
55. Hawkins JS, Casey BM, Lo JY, et al. Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstet Gynecol 2009;113:1307-12.
56. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003;26:S51-61.
57. Moses RG, Barker M, Winter M, et al. Can a low-glycemic index diet reduce the need for insulin in gestational diabetes mellitus? A randomized trial. Diabetes Care 2009;32(6):996-1000.
58. Gabbe SG, Carpenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol 2007;50:1014-24.
59. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343: 1134-8.
60. Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193:118-24.
61. Ramos GA, Jaboson GF, Kirby RS, et al. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol 2007;27:257-8.
62. Kraemer J, Klein J, Lubetsky A, et al. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195:270-4.
63. Heber MF, Ma X, Nraharisetti SB, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85:607-14.
64. Kahn BF, Davies JK, Lynch AM, et al. Predictors of glyburide failure in treatment of gestational diabetes. Obstet Gynecol 2006;107:1303-9.
65. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-15.
66. Moore LE, Clokey D, Rappaport VJ, et al. Metformin compared with glyburide in gestational diabetes. A randomized controlled trial. Obstet Gynecol 2010;115: 55-9.
67. Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients Class A2. Am J Perinatol 1996;13:293-6.
68. Kjos SL, Walther FJ, Montoro M, et al. Prevalence and etiology of respiratory distress in infants of diabetic mothers: predictive values of fetal lung maturity tests. Am J Obstet Gynecol 1990;163:898-903.
69. Lager O, Berkus MD, Huff RW, et al. Shoulder dystocia: should the fetus weighing greater than or equal to 4000 grams be delivered by cesarean section? Am J Obstet Gynecol 1991;165:831-7.
70. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008;31:S12-54.
71. Almario CV, Ecker T, Moroz LA, et al. Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol 2008;198:528 e1-5.
72. Kim C, Tabaei BP, Burke R, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006;96:1643-8.
73. Ferrara A, Peng T, Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus. Diabetes Care 2009;32:269-74.
74. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002;51(2796):803.
75. Berkowitz K, Peters R, Kyos SL, et al. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. Diabetes 1996;45:1572-9.